President, Burnside Development & Associates LLC 9922 Edward Avenue, Bethesda, USA 20814, USA
jfraser@burnsidedev.com
(850) 5245795
Self-employed consultant offering unique knowledge and understanding of, as well as extensive experience with, the interaction of business/government, university/government, and university/business partnerships. Proven strategies for the commercialization of new technology-based innovations. President, Burnside Development & Associates LLC – Consultant, part-time since 1991, full-time since 2015. Burnside is a personal consulting company assisting in all aspects of the creation of technology-based businesses. Emphasis on Innovation, Entrepreneurship, and Commercialization. The Innovation Fund of Serbia. Lead Transaction Specialist in a EU-financed, World Bank-managed program to accelerate academic technology transfer in Serbia’s four largest public universities. 2015 – ongoing. The World Intellectual Property Organization (WIPO). Member of the teaching team for academic technology transfer in seven Southeast Asian countries: Philippines, Malaysia, Thailand, Indonesia, Iran, Mongolia, and Vietnam. Previously served as an expert lecturer six times in their science and technology licensing course offered to member countries. 2017 – ongoing. Member of the International Advisory Board, International Technology Transfer Network, Beijing, China. Advises the organization on strategies to increase the flow of innovative academic business opportunities. 2015 – ongoing. Entrepreneur-in-Residence, National Institute for Standards and Technology, Gaithersburg, MD. Provides entrepreneurial advice to employees. 2016 – ongoing. AUTM Expert in Government of Chile/AUTM contract to assist 15 universities in accelerating technology licensing. Created three Strategic and Operating Plans and Benchmarking Reports. 2012 – 2013. Expert Witness in legal suit: Max Planck, Alnylam Inc. (Plaintiffs) vs. MIT, Whitehead Institute, University of Massachusetts (Defendants). Settled March 2011. Later legal suit of original parties vs. University of Utah – same subject matter. Settled 2015. Assistant Vice President Research & Economic Development and Executive Director, Office of Commercialization, Florida State University, Tallahassee, Florida [1996 – 2014]. Managed a team to create partnerships with outside organizations to build up the research base and develop products and knowledge for the benefit of society. Increased disclosures, licenses, royalties, and R&D income. Over 200 licenses, including 40 spinoffs. Office gross revenues consistently larger than current expenses. Increased faculty awareness and participation in commercialization via regular outreach activities, external speakers, internal ‘Proof of Concept’ funding. Proactively worked with faculty to identify funding sources, prepare applications, and ensure compliance with FSU policies; negotiated terms and conditions of awards, monitored progress, and ensured adherence to funding terms. Major activities with Film School; School of Visual Arts, Theater & Dance; Business; Social Work i.e., non-STEM. President, CEO, Board Director, University Technologies International, Inc., Calgary, Alberta [1989 – 1991]. A for-profit technology transfer company serving the University of Calgary and the Foothills Hospital. Responsible for the strategic direction of the company, liaising with the Board, implementing and monitoring plans, and supervising personnel. Implemented programs to seek new institutional clients on a province-wide basis and to assist clients in creating new technology-based companies. 1990/91 gross revenues of $1 million. Closed an $800,000 deal with Bristol Myers-Squibb. Closed a medical device deal with then-current royalties of $500,000 per year. Independent Consultant, Durham, North Carolina [1988 – 1989]. Agency for International Development (AID), Washington, D.C. On an evaluation team reviewing mid-term progress of a $4.5 million program of PATH, a Seattle-based foundation transferring health care technology to Third World health agencies. A positive review led to a new $13.5 million grant. Research Development Corporation (RDC), Hospital for Sick Children, Toronto. Recommended a new business strategy for the ‘robotics’ division of Cyberfluor Corporation, an RDC-created company. Executive Vice President, University Technology Corporation, Durham, North Carolina [1986 – 1989]. Cofounder. Launched as a for-profit company serving as the exclusive licensing agent for five universities. Created the business plan and raised $3.5 million in private sector funds. Responsible for the overall operations of the company, including budget preparation, daily operations, and long-term planning. Responsible for hiring and managing in-house staff as well as the on-campus Technology Liaison Officers (TLOs) at the University of Maryland and the University of Connecticut. Negotiated the addition of the Smithsonian Institution as a UTC client. After three years of operations, sold to USET Inc., a subsidiary of Macmillan Publishing, New York. Consultant, Toronto, Ontario [1984 – 1986]. Self-employed consultant in technology commercialization and new venture financing. BIOS, Toronto. Three-person start-up – biomedical subscription information service company (Canada/Northern US). Introduced health care opportunities in small businesses, universities, and hospitals to large health care corporations. Capsule Technology International Limited, Windsor. Directed a campaign winning the prestigious ‘Canada Business Awards for Excellence – Entrepreneur for the Year – 1986.’ CTIL was a highly successful manufacturer/supplier in the international pharmaceutical industry. Obtained a $150,000 R&D grant for the firm. Vice President, Development, Technology Development Corporation (TDC), Toronto, Ontario [1980 – 1984]. Venture capital firm. Responsibilities included assessing high-tech investment opportunities, structuring legal agreements, preparing business plans, arranging appropriate government financing, and monitoring progress toward goals in the plans. Directed an in-depth evaluation of a New York City-based opportunity in cancer detection. Arranged for a two-stage $15 million equity investment for the startup phase of the business. Guided MOLI Energy Limited through the R&D phase into early commercialization. MOLI was a University of British Columbia spinout company commercializing rechargeable lithium battery technology. Responsibilities included hiring the President of Duracell Canada as the President of MOLI to guide its growth and steering a $2.6 million grant application through federal channels that later became a $10 million package, including non-interest-bearing loans. Awards Officer, Natural Sciences & Engineering Research Council (NSERC), Ottawa, Ontario [1973 – 1980]. Senior officer responsible for the administration of Canada’s largest peer-adjudicated R&D grants program ($96 million in 1980). Responsible for policy and program changes. Directed a staff of 20. NSERC was responsible for the annual distribution of $125 million (1980) to support the research of 5,500 scientists and engineers in Canadian universities. NSERC is the counterpart of the NSF in the U.S. Education 2012 – Earned and Maintain Registered Technology Transfer Professional (RTTP) designation. 2011 – Earned and Maintain Certified Licensing Practitioner (CLP) designation. 1973 – M.A. Biochemistry, University of California at Berkeley. 1970 – Graduate School, University of Massachusetts. 1969 – B.Sc. Chemistry, 1st Class Honours, Carleton University, Ottawa, Ontario.
